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At 21 months after transplantation the recipient had a great increase in transferrin saturation at 94% with a normal serum ferritin of 103 µg/l. Hepatic iron concentration at four months was 20 µmol/g and at 22 months was 22.3 µmol/g (normal 0-35 µmol/g). Genetic testing for haemochromatosis 4 on his liver graft revealed homozygosity for the C282Y mutation of the HFE gene. Genetic testing on a peripheral blood sample at 21 months was normal (wild type) for the C282Y mutation. The donor family was investigated for haemochromatosis (fig 1) . A brother of the donor was an iron loaded homozygote and her mother appeared to be a nonexpressing homozygote. The mother had a non-identical twin that was homozygous for the C282Y mutation with abnormal iron studies.
Conclusions-This case suggests that the genetic defect of haemochromatosis has been transplanted into the recipient with the donor intestine and that iron accumulation will probably occur with time. Within 21 months of transplantation the recipient is showing evidence of the typical biochemical abnormality seen in a young patient with haemochromatosis, namely an increase in transferrin saturation with a normal hepatic iron concentration. Although the serum ferritin is normal, it is likely that if untreated it will continue to rise with time. Therefore, we have identified a predisposition to future iron overload rather than iron overload at 21 months. The concomitant transplantation of the haemochromatosis liver is less likely to be contributing to the abnormal iron metabolism. Transplantation of a haemochromatosis liver alone into a normal recipient has been previously documented at this centre with a progressive decline in hepatic iron concentration and a normal radioiron absorption study. 5 This supports the hypothesis that the fundamental defect in haemochromatosis is site specific at the level of the intestine rather than a systemic abnormality. 
